Kalaris Therapeutics, Inc. (KLRS) Insider Trading

Name: Kalaris Therapeutics, Inc. (KLRS) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 28, 2026): Vandekop Amy O'Leary (VP, Corporate Controller): Grant/Award of 10,000 shares.

Get alerted when insiders trade KLRS

Email address

Loading company data...

Beta

Loading company details...

Beta